ORCID as entered in ROS

Select Publications
2021, 'Elotuzumab', in Resistance to Targeted Anti-Cancer Therapeutics, Springer International Publishing, pp. 73 - 82, http://dx.doi.org/10.1007/978-3-030-73440-4_6
,2017, 'Autoimmune disorders', in Clinical Manual of Blood and Bone Marrow Transplantation, pp. 221 - 228, http://dx.doi.org/10.1002/9781119095491.ch25
,